SPIA
ETON icon

Steward Partners Investment Advisory’s Eton Pharmaceutcials ETON Stock Holding History

Steward Partners Investment Advisory’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,064
Closed -$200K – 4296
2025
Q2 		$200K Buy
14,064
+6,565
+88% +$104K ﹤0.01% 1763
2025
Q1 		$97.3K Buy
+7,499
New +$113K ﹤0.01% 2028

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Steward Partners Investment Advisory's ETON Position: Q3 2025 in Review

Steward Partners Investment Advisory sold out of Eton Pharmaceutcials (ETON) in Q3 2025, closing a stake of 14,064 shares — an estimated $200K sold.

Steward Partners Investment Advisory first reported a position in ETON in Q1 2025 and held it in 2 quarters. The position peaked at $200K in Q2 2025. 103 funds tracked by Wall St. Rank hold ETON as of Q3 2025.

  • Steward Partners Investment Advisory reported no remaining Eton Pharmaceutcials position as of Q3 2025 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 14,064 Eton Pharmaceutcials shares in Q3 2025, an estimated $200K.
  • Steward Partners Investment Advisory first reported a position in Eton Pharmaceutcials in Q1 2025 and held it in 2 quarters.
  • Steward Partners Investment Advisory's Eton Pharmaceutcials position peaked at $200K in Q2 2025.
  • 103 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2025, filed 12 Nov 2025.